Metformin, a widely used and affordable diabetes drug, could prevent a form of acute myeloid leukemia in people at high risk ...

Researchers found metformin, a common diabetes drug, may protect against blood cancer AML by targeting pre-cancerous cells.

Scientists discovered two genes involved in hyperemesis gravidarum, a condition that can cause extreme nausea and vomiting ...

A widely used diabetes drug holds promise in the treatment of the third biggest cancer killer in the UK, new research ...

Researchers at Mass General Brigham found that by December 2023, over one-third of all new prescriptions for type 2 diabetes ...

Research from the University of Cambridge shows that metformin, a widely used and affordable diabetes drug, could prevent a ...

Researchers found that by December 2023, more than 1 in 3 of the medications being started for type 2 diabetes treatment were GLP-1RA-based medications.

A concerning number of newly diagnosed patients discontinue their medication within a year. Nearly 40% of patients diagnosed ...

As CMS maintains limits on GLP-1 coverage for weight loss, new efficacy data and shifting prescribing patterns point to sustained high demand across the drug class. Here are four updates: 1. Federal ...

Metformin, a widely used and affordable diabetes drug, could prevent a form of acute myeloid leukaemia in people at high risk of the disease, a study ...